Health, Longevity & Biohacking
Andrew Scull cites NIMH trial reporting 67–82% antipsychotic dropouts
Lex Fridman Podcast
Psychiatry, Insane Asylums, Mental Illness, ECT, Lobotomies, Freud & Jung | Lex Fridman Podcast #502
What was said
""Between 67 and 82% of the patients, depending on which drug they were on, dropped out of the trial because either the drug wasn't working or they couldn't stand the side effects.""
Andrew Scull cites an NIMH-funded antipsychotic comparison trial he says was published in the New England Journal of Medicine. He says newer second-generation drugs were no more effective than an older first-generation drug, and that 67% to 82% discontinued due to poor effect or intolerable side effects.
Verification status
Attributed speaker claim
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
Source and context
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
- Speaker
- Andrew Scull · guest
- Programme
- Lex Fridman Podcast
- Episode
- Psychiatry, Insane Asylums, Mental Illness, ECT, Lobotomies, Freud & Jung | Lex Fridman Podcast #502
- Clip time
- 3:09:42
- Original source
- Watch the source segment →
From this episode
Lex Fridman Podcast